Thomas Elebring
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Synthesis and Biological Evaluation 4
-
- Neurotransmitter Receptor Influence on Behavior 6
- Co-authors
- Peter J. Greasley (3 shared papers)Stephan Hjorth (2 shared papers)Erik Ryberg (2 shared papers)Niklas Larsson (2 shared papers)Nils-Olov Hermansson (1 shared paper)S. Sjögren (1 shared paper)Tomáš Drmota (1 shared paper)Peter Nilsson (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)British Journal of Pharmacology (3 papers)Gastroenterology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)The Journal of Organic Chemistry (2 papers)
- Partner nations
- SwedenUnited KingdomCanada
In The Last Decade
Thomas Elebring
25 papers receiving 1.9k citations
Thomas Elebring's Hit Papers
Peers
Comparison fields: 5 of 99
- Pharmacology 1.3k
- Cellular and Molecular Neuroscience 680
- Toxicology 78
- Endocrine and Autonomic Systems 137
- Endocrinology, Diabetes and Metabolism 233
Countries citing papers authored by Thomas Elebring
This map shows the geographic impact of Thomas Elebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Elebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Elebring more than expected).
Fields of papers citing papers by Thomas Elebring
This network shows the impact of papers produced by Thomas Elebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Elebring. The network helps show where Thomas Elebring may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Elebring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The orphan receptor GPR55 is a novel cannabinoid receptor Hit paper breakdown → | 2007 | 1249 |
| 2 | 2000 | 208 | |
| 3 | 2004 | 109 | |
| 4 | 1991 | 64 | |
| 5 | 2007 | 56 | |
| 6 | 2011 | 49 | |
| 7 | 2002 | 40 | |
| 8 | 2009 | 39 | |
| 9 | 1987 | 17 | |
| 10 | 1982 | 15 | |
| 11 | 2012 | 14 | |
| 12 | 1993 | 13 | |
| 13 | 1994 | 10 | |
| 14 | 1985 | 9 | |
| 15 | 2008 | 9 | |
| 16 | 2007 | 8 | |
| 17 | 1993 | 8 | |
| 18 | 2005 | 7 | |
| 19 | 2008 | 6 | |
| 20 | 1988 | 5 |
About Thomas Elebring
Thomas Elebring is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience, Molecular Biology, Surgery and Pharmacology, having authored 25 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (6 papers), Dysphagia Assessment and Management (4 papers), Synthesis and Biological Evaluation (4 papers), Receptor Mechanisms and Signaling (4 papers), Gastroesophageal reflux and treatments (4 papers), Computational Drug Discovery Methods (3 papers), Analytical Chemistry and Chromatography (3 papers) and Cannabis and Cannabinoid Research (3 papers). The work is most often cited by research in Pharmacology (1.3k citations), Cellular and Molecular Neuroscience (680 citations), Toxicology (78 citations), Endocrine and Autonomic Systems (137 citations) and Endocrinology, Diabetes and Metabolism (233 citations). Thomas Elebring has collaborated with scholars based in Sweden, United Kingdom and Canada. Frequent co-authors include Peter J. Greasley, Stephan Hjorth, Erik Ryberg, Niklas Larsson, Nils-Olov Hermansson, S. Sjögren, Tomáš Drmota, Peter Nilsson, Sverker von Unge and Lanna Li. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology, Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.